XML 45 R39.htm IDEA: XBRL DOCUMENT v3.25.2
Condensed Consolidated Financial Statement Details - Schedule of Liability Related to Sale of Potential Future Royalties (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
 [1]
Jun. 30, 2025
Jun. 30, 2024
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Liabilities related to the sales of future royalties, net – beginning balance     $ 91,776  
Non-cash royalty revenue     (21,635) $ (32,298)
Non-cash interest expense $ 5,394 $ 6,408 10,368 $ 11,939 [1]
Amortization of transaction costs     64  
Liabilities related to the sales of future royalties, net – ending balance 80,573   80,573  
2012 Purchase and Sale Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Liabilities related to the sales of future royalties, net – beginning balance     7,197  
Non-cash royalty revenue     (3,474)  
Non-cash interest expense     1,294  
Amortization of transaction costs     0  
Liabilities related to the sales of future royalties, net – ending balance 5,017   5,017  
2020 Purchase and Sale Agreement        
Collaborative Arrangements and Non-collaborative Arrangement Transactions [Line Items]        
Liabilities related to the sales of future royalties, net – beginning balance     84,579  
Non-cash royalty revenue     (18,161)  
Non-cash interest expense     9,074  
Amortization of transaction costs     64  
Liabilities related to the sales of future royalties, net – ending balance $ 75,556   $ 75,556  
[1] All share and per share amounts have been retrospectively adjusted to reflect a one-for-fifteen reverse stock split (see Note 6).